Ask AI
ARROS 1
ARROS-1: Phase I/II Study of Zidesamtinib for Patients With Advanced ROS1+ NSCLC After Prior ROS1 TKI

Released: November 17, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: November 17, 2025